Study design: Administration of the walking index for SCI (WISCI) II is recommended to assess walking in spinal cord injury (SCI) patients. Determining the reliability and reproducibility of the WISCI II in acute SCI would be invaluable. Objectives: The objective of this study is to assess the reliability and reproducibility of the WISCI II in patients with traumatic, acute SCI. Design: Test-retest analysis and calculation of reliability and smallest real difference (SRD). Setting: SCI unit of a rehabilitation hospital. Methods: Thirty-three patients, median age 44 years, median time since onset of SCI 40 days. Level: 20 cervical, 8 thoracic, 5 lumbar; ASIA (American Spinal Injury Association) impairment scale (AIS) grade: 32 D/1 C. Assessment of maximum WISCI II levels by two trained, blinded raters to evaluate interrater (IRR) and intrarater reliability. Results: The intrarater reliability was 0.999 for therapists A and 0.979 for therapists B, for the maximum WISCI II level. The IRR for the maximum WISCI II score was 0.996 on day 1 and 0.975 on day 2. The SRD for the maximum WISCI II score was 1.147 for tetraplegics and 1.682 for paraplegics. These results suggest that a change of two WISCI II levels could be considered real.
Conclusions:The WISCI II has high IRR and intrarater reliability and good reproducibility in the acute and subacute phase when administered by trained raters. Spinal Cord (2014) 52, 65-69; doi:10.1038/sc.2013.127; published online 22 October 2013Keywords: spinal cord injury; walking; WISCI II; reliability; reproducibility
INTRODUCTIONValid and reliable outcome measures in clinical trials on spinal cord injuries (SCIs) must be generated to develop effective treatment interventions-a necessity that is particularly true for walking function, which is a principal goal for subjects with SCIs. 1 Thus, it is conceivable that many clinical trials will be geared toward walking recovery and require valid outcome measures. Outcome measures that are related to walking function include measures of walking capacity, such as short-distance timed walk, long distance (6-min walk) and the walking index for SCI (WISCI II).The WISCI was introduced in 2000 2 and modified in 2001 (WISCI II) 3 as a measure of the capacity to walk for use in clinical trials, incorporating the use of walking aids, braces and physical assistance on a 21-point scale. The WISCI was ranked by an international group of SCI clinicians and investigators from most impaired to least impaired, and has demonstrated theoretical construct and face validity. It was subsequently compared with four scales in a clinical population of mixed SCI and spinal cord lesions to validate its retrospective criteria (versus other scales). 4 In 2006, the WISCI was used in a multicenter, randomized clinical trial, as assessed by blinded observers, and correlated well with lower extremity motor score, balance, walking speed, 6-min walking distance and locomotor functional independence measure score, validating its prospective criteria. 5 Since then, the WISCI ...